Development and Validation of a Stability-Indicating HPTLC Method for Analysis of Rasagiline Mesylate in the Bulk Drug and Tablet Dosage Form

Table 4

Recovery studies^a.

Excess drug added to the analyte (%)	Amount of drug found (ng)	% Recovery	% RSD
0	100.0	99.10	0.72
50	151.6	101.06	0.49
100	198.4	99.21	0.31
150	252.2	100.88	0.44

Matrix containing 100 ng of drug. ^a𝑛=6.